Why Taiwan became the defining issue in the Trump-Xi talks
U.S. President Donald Trump had said arms sales to Taiwan would be on the agenda for his talks with Chinese President Xi Jinping which ended Friday.
Trump went big on tech stocks in first quarter of 2026, new filings show
Trump bought shares of Amazon, Meta, Oracle, Broadcom, Motorola and Dell worth millions, new ethics disclosure filings show.
Trump says China and Taiwan should 'both cool it'
President Donald Trump spoke about Taiwan after a two-day visit to China, where he said he discussed Iran, and trade deals with Chinese President Xi Jingping.
Russia's Putin to meet China's Xi in Beijing from May 19-20, Beijing and Moscow say
Putin's trip follows shortly after U.S. President Donald Trump's visit to Beijing.
Bill Ackman built Microsoft stake in first quarter during sell-off, betting on AI and cloud growth
Bill Ackman's Pershing Square Capital Management has built a position in Microsoft, the billionaire hedge fund manager said Friday in a post on X.
What you need to know about Nvidia competitor Cerebras after wild IPO
Nvidia competitor Cerebras made a stunning debut on Wall Street Thursday, signaling unstoppable demand for AI chips. Here's how its chips compete with Nvidia's.
FDA shuffles top drug, biologics leaders in latest shakeup
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.
Berkshire Hathaway returns to airlines with $2.6 billion stake in Delta Air Lines
The Omaha-based company built a position worth more than $2.6 billion, making Delta Berkshire's 14th-largest holding at the end of March.
Maine might boot Sen. Susan Collins. It could hurt the state's wallet for years
Sen. Susan Collins is the lone New England Republican left in Congress and chairs the Senate Appropriations Committee.
Jim Cramer fears SpaceX's IPO could be 'destructive' for the rest of market
CNBC's Jim Cramer said he is growing concerned about the speculative nature in the IPO market.
Trump touted Palantir on Truth Social after buying the company's stock, records show
During the first three months of the year, Trump purchased between $630,000 and $247,008 worth of Palantir stock and sold at least $1.1 million.
Traders now see next Fed interest rate move as a hike following inflation surge
The fed funds futures market is pricing in an increase as soon as December.
Democrats blast Trump over 'slush fund' in possible IRS lawsuit settlement
ABC News reported President Donald Trump could settle a lawsuit against the IRS in exchange for a $1.7 billion fund to compensate his allies.
Stephen Miran exits the Fed. How he set the stage for Kevin Warsh.
The outgoing Fed governor shares big ideas with the incoming chair.
Can the S&P 500 hold on for a 7th weekly gain? Plus, Friday's best and worst stocks
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
How China and U.S. eased the Middle East oil shock and kept prices from spiking even higher
China and the U.S., the world's two largest economies, wield great influence over the oil market and are using it to help plug the supply gap.
Chinese EVs are coming to Canada, and some dealers can't wait to sell them
Canada is allowing 49,000 Chinese-made electric vehicles to be imported for retail sales annually at a tariff rate of 6.1%.
NFL wants certain trading contracts banned from prediction markets like 'first play of game,' injuries
The letter, which was reviewed by CNBC, calls for banning certain contracts and raising the age requirements for participation on sports-related contracts.
Inflation rate projected to hit 6% in the second quarter, top economic forecasters say
The recent surge in inflation is likely to get worse over the next several months, according to a survey Friday.
Starbucks to lay off 300 U.S. employees, shutter some regional support offices
Starbucks said the moves will help the coffee chain return to profitable growth.
Exxon's once-hefty dividend is now tiny. Here's how to fix that
Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration
U.S. drugmaker Bristol Myers Squibb inked a partnership with a Chinese company that some say could mark the next wave of collaboration across continents.
Trump-Xi summit: The 3 big takeaways from historic meeting in Beijing
The two-day meeting wrapped up Friday, setting the tone for further U.S.-China talks this year.
Detroit automakers have cut more than 20,000 U.S. salaried jobs as AI threat looms
Reasons for the job declines vary by automaker, but are generally tied to evolving technological changes in the industry — including the rise of AI.